Pfizer Progresses Combo Covid Vaccine. It's Competing with Moderna.

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Pfizer and BioNTech said an early trial of a combined Covid-19 and influenza vaccine had produced positive data. The companies are set for a race with...

Pfizer and BioNTech said Thursday that an early trial of a combined Covid-19 and influenza vaccine had produced positive data. The companies are set for a race with Moderna to release their combination vaccines.

Pfizer and German partner BioNTech said the shot performed well in tests which compared it with two stand-alone vaccines. They expect to start a Phase 3 trial within the coming months. “This vaccine has the potential to lessen the impact of two respiratory diseases with a single injection and may simplify immunization practices for providers, patients, and healthcare systems all over the world,” said Annaliesa Anderson, head of Vaccine Research and Development at Pfizer.

Pfizer shares were down 0.2% in premarket trading on Thursday. American depositary receipts of BioNTech were up 0.3%. The companies will be racing against Moderna , which said earlier this month that its own combination vaccine could be ready to launch as soon as 2025.

Source: News Formal (newsformal.com)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna doses 1st participant in phase 3 clinical trial of combo flu, COVID vaccineThe company said a combo vaccine could raise overall coverage rates.
Source: ABC - 🏆 471. / 51 Read more »

Pfizer and BioNTech announce positive data in early trial of flu/COVID combination vaccineCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Source: MarketWatch - 🏆 3. / 97 Read more »

Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive dataPfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.
Source: NBCLA - 🏆 319. / 59 Read more »

Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive dataPfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.
Source: CNBC - 🏆 12. / 72 Read more »

'For Shame': Pfizer to Charge $1,390 for Lifesaving Covid Drug That Costs Just $13'Pfizer treats Paxlovid like a Prada handbag; a luxury for the few rather than a treatment for the many,' said one consumer advocate.
Source: commondreams - 🏆 530. / 51 Read more »

'Daylight Robbery': Pfizer Condemned for Hiking US Covid Vaccine Price by 10,000% Above Cost'While health workers and the vulnerable continue to go unvaccinated in developing countries, Pfizer is shamelessly fleecing the public for ever-greater sums of money,' said one campaigner.
Source: commondreams - 🏆 530. / 51 Read more »